Global Automated Test Equipment Market Research Report 2018

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Automated Test Equipment Market, By Product

7.1.  Automated Test Equipment Market, by Product, 2021-2030

7.1.1.    Non-Memory ATE

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Memory ATE

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Discrete ATE

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Automated Test Equipment Market, By Vertical

8.1.  Automated Test Equipment Market, by Vertical, 2021-2030

8.1.1.    Automotive

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Consumer

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Aerospace & Defense

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    IT & Telecommunications

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Others

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Automated Test Equipment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2016-2030)

9.1.2.    Market Revenue and Forecast, by Vertical (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2016-2030)

9.2.2.    Market Revenue and Forecast, by Vertical (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2016-2030)

9.3.2.    Market Revenue and Forecast, by Vertical (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2016-2030)

9.4.2.    Market Revenue and Forecast, by Vertical (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2016-2030)

9.5.2.    Market Revenue and Forecast, by Vertical (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Vertical (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Vertical (2016-2030)

Chapter 10.  Company Profiles

10.1.              Aemulus Holdings Bhd (“Aemulus”)

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Chroma ATE Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Aeroflex Inc. (a subsidiary of Cobham plc)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Astronics Corporation

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Advantest Corporation

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              LTX-Credence Corporation (Xcerra Corporation)

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Teradyne Inc.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              STAr Technologies Inc. (a subsidiary of Innotech Corporation)

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Tesec Corporation

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Roos Instruments, Inc.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Marvin Test Solutions Inc.

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Danaher Corporation

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Frequently Asked Questions

The global pharmerging market size was reached at USD 1.48 trillion in 2021 and it is anticipated to hit around US$3.21 trillion by 2030.

The global pharmerging market is expected to drive growth at a CAGR of 8.98% from 2022 to 2030.

The major players operating in the pharmerging market are Sanofi S.A., Pfizer Inc., AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG (Roche AG), Novartis AG, Teva Pharmaceutical Limited., Eli Lilly and Company, Johnson & Johnson Corporation, and Abbott Laboratories.

The Pharmerging market is a growing market in developing and under developed countries which deals with pharmaceutical companies.

Asia Pacific region will lead the global pharmerging market over the forecast period 2022 to 2030.

Report Details

  • Report Code:1767
  • Category:Machinery and Equipment
  • No. of Pages:119
  • Format:PDF/PPT/Excel
  • Published:March 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers